BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of October 24, 2026, BRTX trades at $1.65 with a market cap of $2.07M and a P/E ratio of -2.10. BRTX moved -3.33% today. Year to date, BRTX is -93.23%; over the trailing twelve months it is -94.86%. Its 52-week range spans $1.28 to $42.00. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BRTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.65 |
| Market Cap | $2.07M |
| P/E Ratio | -2.10 |
| EPS | $-1.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.00 |
| 52-Week Low | $1.28 |
| Volume | 813 |
| Avg Volume | 0 |
| Revenue (TTM) | $357.87K |
| Net Income | $-11.06M |
| Gross Margin | 92.09% |
1 analysts cover BRTX: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.